Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1998 Nov;53(11):953–956. doi: 10.1136/thx.53.11.953

Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease

A Bhowmik 1, T Seemungal 1, R Sapsford 1, J Devalia 1, J Wedzicha 1
PMCID: PMC1745116  PMID: 10193394

Abstract

BACKGROUND—Although sputum induction is used as a technique to investigate lower airway inflammation in asthmatic subjects, advantages over spontaneous sputum in patients with chronic obstructive pulmonary disease (COPD) have not been investigated.
METHODS—Samples of spontaneous sputum and sputum induced with 3% hypertonic saline for 14 minutes were collected from 27 patients with chronic obstructive pulmonary disease (COPD) who usually produced spontaneous sputum. Spirometric indices and oxygen saturation (SaO2) were measured at seven minute intervals. The spontaneous, seven and 14 minute sputum samples were analysed for total and differential cell counts, cell viability, and interleukin 8levels.
RESULTS—Analysis of the sputum revealed that median cell viability was higher in the seven minute (62.8%; p = 0.004) and 14 minute (65%; p = 0.001) induced sputum samples than in spontaneous sputum (41.2%). There was no significant difference in total and differential cell counts or in interleukin 8 levels between spontaneous and induced sputum. During the sputum induction procedure the mean (SD) fall in forced expiratory volume in one second (FEV1) was 0.098 (0.111) l (p < 0.001) and in forced vital capacity (FVC) was 0.247 (0.233) l (p < 0.001). There was a small but significant fall in SaO2 during sputum induction (p = 0.03).
CONCLUSIONS—Induced sputum contains a higher proportion of viable cells than spontaneous sputum. There are no significant differences between the sputum samples obtained at seven minutes and at 14minutes of hypertonic saline nebulisation. Sputum induction is safe and well tolerated in patients with COPD.



Full Text

The Full Text of this article is available as a PDF (96.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Efthimiadis A., Pizzichini M. M., Pizzichini E., Dolovich J., Hargreave F. E. Induced sputum cell and fluid-phase indices of inflammation: comparison of treatment with dithiothreitol vs phosphate-buffered saline. Eur Respir J. 1997 Jun;10(6):1336–1340. doi: 10.1183/09031936.97.10061336. [DOI] [PubMed] [Google Scholar]
  2. Fahy J. V., Liu J., Wong H., Boushey H. A. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis. 1993 May;147(5):1126–1131. doi: 10.1164/ajrccm/147.5.1126. [DOI] [PubMed] [Google Scholar]
  3. Fahy J. V., Wong H., Liu J., Boushey H. A. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am J Respir Crit Care Med. 1995 Jul;152(1):53–58. doi: 10.1164/ajrccm.152.1.7599862. [DOI] [PubMed] [Google Scholar]
  4. Holz O., Jörres R. A., Koschyk S., Speckin P., Welker L., Magnussen H. Changes in sputum composition during sputum induction in healthy and asthmatic subjects. Clin Exp Allergy. 1998 Mar;28(3):284–292. doi: 10.1046/j.1365-2222.1998.00243.x. [DOI] [PubMed] [Google Scholar]
  5. Keatings V. M., Collins P. D., Scott D. M., Barnes P. J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996 Feb;153(2):530–534. doi: 10.1164/ajrccm.153.2.8564092. [DOI] [PubMed] [Google Scholar]
  6. Lacoste J. Y., Bousquet J., Chanez P., Van Vyve T., Simony-Lafontaine J., Lequeu N., Vic P., Enander I., Godard P., Michel F. B. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 1993 Oct;92(4):537–548. doi: 10.1016/0091-6749(93)90078-t. [DOI] [PubMed] [Google Scholar]
  7. Linden M., Rasmussen J. B., Piitulainen E., Tunek A., Larson M., Tegner H., Venge P., Laitinen L. A., Brattsand R. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis. 1993 Nov;148(5):1226–1232. doi: 10.1164/ajrccm/148.5.1226. [DOI] [PubMed] [Google Scholar]
  8. Nightingale J. A., Rogers D. F., Barnes P. J. Effect of repeated sputum induction on cell counts in normal volunteers. Thorax. 1998 Feb;53(2):87–90. doi: 10.1136/thx.53.2.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pavord I. D. Sputum induction to assess airway inflammation: is it an inflammatory stimulus? Thorax. 1998 Feb;53(2):79–80. doi: 10.1136/thx.53.2.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pin I., Gibson P. G., Kolendowicz R., Girgis-Gabardo A., Denburg J. A., Hargreave F. E., Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992 Jan;47(1):25–29. doi: 10.1136/thx.47.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pizzichini E., Pizzichini M. M., Efthimiadis A., Evans S., Morris M. M., Squillace D., Gleich G. J., Dolovich J., Hargreave F. E. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):308–317. doi: 10.1164/ajrccm.154.2.8756799. [DOI] [PubMed] [Google Scholar]
  12. Pizzichini E., Pizzichini M. M., Efthimiadis A., Hargreave F. E., Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J. 1996 Jun;9(6):1174–1180. doi: 10.1183/09031936.96.09061174. [DOI] [PubMed] [Google Scholar]
  13. Pizzichini M. M., Popov T. A., Efthimiadis A., Hussack P., Evans S., Pizzichini E., Dolovich J., Hargreave F. E. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):866–869. doi: 10.1164/ajrccm.154.4.8887576. [DOI] [PubMed] [Google Scholar]
  14. Popov T., Gottschalk R., Kolendowicz R., Dolovich J., Powers P., Hargreave F. E. The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy. 1994 Aug;24(8):778–783. doi: 10.1111/j.1365-2222.1994.tb00990.x. [DOI] [PubMed] [Google Scholar]
  15. Seemungal T. A., Donaldson G. C., Paul E. A., Bestall J. C., Jeffries D. J., Wedzicha J. A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1418–1422. doi: 10.1164/ajrccm.157.5.9709032. [DOI] [PubMed] [Google Scholar]
  16. Stănescu D., Sanna A., Veriter C., Kostianev S., Calcagni P. G., Fabbri L. M., Maestrelli P. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax. 1996 Mar;51(3):267–271. doi: 10.1136/thx.51.3.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. in 't Veen J. C., de Gouw H. W., Smits H. H., Sont J. K., Hiemstra P. S., Sterk P. J., Bel E. H. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J. 1996 Dec;9(12):2441–2447. doi: 10.1183/09031936.96.09122441. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES